DANIELLE GUMINA: Open Payments
NPI 1760728687 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,945 in 104 payments from 21 companies in 2025. Trend: 2023 $1,612 · 2024 $2,345 · 2025 $1,945
Food & beverage: $1,945
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $274 |
| Corcept Therapeutics | 16 | $225 |
| Amgen Inc. | 13 | $213 |
| Novo Nordisk Inc | 11 | $193 |
| Almatica Pharma LLC | 7 | $149 |
| Xeris Pharmaceuticals, Inc. | 6 | $127 |
| Lilly USA, LLC | 7 | $125 |
| ABBVIE INC. | 5 | $117 |
| IBSA Pharma Inc. | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
Products named: LEQVIO, Korlym, TERIPARATIDE, REPATHA, MOUNJARO, SYNTHROID, GVOKE HYPOPEN, Tirosint.
Industry payments across FL — which companies pay providers there.
